Earlier quoted context omitted.
Do you feel the same way about FDA approvals? I mean, it seems like common sense - a limited beta test before widespread rollout. I'm not convinced they'll ever come up with a good framework for dealing with the cyber & bio issues, but getting triggered by a beta test rollout seems overboard.
The difference is that FDA approvals are a well-defined process with specific and actionable criteria for the release of a new product. Whereas this is the administration running on vibes and favouritism
Perhaps you can fault them with not coming up with an objective framework earlier, but that's a different criticism.